Obesity Due to Pomc Deficiency

• FDA approval · 2024-12-20
  FDA Approved: IMCIVREE — Supplemental Application (Rhythm Pharmaceuticals, Inc)

  The FDA approved a supplemental application for IMCIVREE (setmelanotide) filed by Rhythm Pharmaceuticals.

• FDA approval · 2020-11-25
  FDA Approved: IMCIVREE — Original Application (Rhythm Pharmaceuticals, Inc)

  FDA approved IMCIVREE (setmelanotide) from Rhythm Pharmaceuticals in its original NDA.